Table 2.
Clinicopathological features of altered and unaltered patients with LUSC from TCGA
| Unaltered(n = 59) | Altered(n = 119) | p-value | ||
|---|---|---|---|---|
| Sex | 0.278 | |||
| Female | 19 | 28 | ||
| Male | 40 | 91 | ||
| Age | 0.386 | |||
| < 65 | 15 | 40 | ||
| ≥ 65 | 42 | 78 | ||
| NA | 2 | 1 | ||
| Race | 0.769 | |||
| White | 41 | 72 | ||
| Non-white | 4 | 10 | ||
| NA | 14 | 37 | ||
| Smoking_history | 1.000 | |||
| Yes | 57 | 116 | ||
| No | 2 | 3 | ||
| Cancer_status | 0.658 | |||
| With cancer | 10 | 18 | ||
| Cancer free | 49 | 101 | ||
| Pathologic_stage | 0.978 | |||
| I | 34 | 65 | ||
| II | 12 | 27 | ||
| III | 12 | 23 | ||
| IV | 1 | 2 | ||
| NA | 0 | 2 | ||
| T stage | 0.539 | |||
| T1 | 16 | 21 | ||
| T2 | 35 | 80 | ||
| T3 | 4 | 10 | ||
| T4 | 4 | 8 | ||
| N stage | 0.521 | |||
| N0 | 40 | 76 | ||
| N1 | 10 | 29 | ||
| N2 | 6 | 11 | ||
| N3 | 2 | 3 | ||
| NX | 1 | 0 | ||
| M stage | 0.172 | |||
| M0 | 53 | 112 | ||
| M1 | 1 | 2 | ||
| MX | 4 | 2 | ||
| NA | 1 | 3 |
Altered, LUSC patients with mutation and/or copy number variation; Unaltered, LUSC patients without mutation and/or copy number variation; LUSC lung squamous cell cancer, TCGA The Cancer Genome Atlas